Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Letter
Nature Medicine 14, 1370-1376 (1 December 2008) | doi:10.1038/nm.1879;
Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease
&
Abstract
Blockade of mineralocorticoid receptor has been shown to improve the clinical outcomes of proteinuric kidney diseases. However, little is known about the regulation of mineralocorticoid receptor–dependent transcriptional activity in renal disease.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
